HopeStage
Back to all studies
WithdrawnNCT00399022

Treatment With Duloxetine for OCD Patients

Medication studyAges 18–65Israel
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Ramat GanSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Withdrawn
Enrollment listed in the registry
40
Sponsor
Sheba Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
Israel
Age range
From 18 Years to 65 Years
Official registry ID
NCT00399022
Official title
Show the full official title

Treatment With Duloxetine for OCD Patients

Recruitment & locations

Withdrawn

Ramat Gan

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sheba Medical Center, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Duloxetine.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies